CGS 9343B

CAS : 109826-27-9

Ref. 3D-JEA82627

Informations sur le produit

• Nom: CGS 9343B
• Synonymes: 1-{1-[(4-methyl-4H,6H-pyrrolo[1,2-a][4,1]benzoxazepin-4-yl)methyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one, 1-{1-[(4-methyl-4H,6H-pyrrolo[1,2-a][4,1]benzoxazepin-4-yl)methyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one (2Z)-but-2-enedioate, 2H-Benzimidazol-2-one, 1,3-dihydro-1-[1-[(4-methyl-4H,6H-pyrrolo[1,2-a][4,1]benzoxazepin-4-yl)methyl]-4-piperidinyl]-, (Z)-2-butenedioate (1:1), 4H,6H-Pyrrolo[1,2-a][4,1]benzoxazepine, 2H-benzimidazol-2-one deriv., Cgs-9343B, Kw-5617, Zaldaride maleate, Zy-17617B
• CAS: 109826-27-9

Description

CGS 9343B is a fatty acid that binds to calcium and calmodulin. It has been shown to have cytosolic calcium-dependent activity in skin cells, which may be due to its ability to induce the release of epidermal growth factor (EGF). CGS 9343B also inhibits atp levels and ATP-sensitive potassium channels in experimental models. This drug has been shown to inhibit the growth of diarrheal pathogens such as Clostridium difficile and Salmonella enterica.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 544.61 g/mol
• Formule: C₂₆H₂₈N₄O₂·C₄H₄O₄
• Degré de pureté: Min. 95%